Comparing two treatments for fever and low blood counts during cancer care
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial looks at whether adding a medicine called G-CSF (which helps the body make more white blood cells) to antibiotics is better than antibiotics alone for children with cancer who develop a fever and low blood cell counts after chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 16 years old.
- You have been diagnosed with cancer that affects your blood or other parts of the body.
- You are currently receiving chemotherapy.
- You have a fever and low white blood cell count (neutropenia).
- You have not already received G-CSF or antibiotics for this fever before coming to the hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether proteins in your blood can predict complications when you have a fever and very low white blood cells after cancer treatment. It aims to help doctors choose the best antibiotics early on.
This trial tests whether an antibiotic called ceftazidime-avibactam (CAZ-AVI) can help patients with blood cancers who have a fever and very low infection-fighting white blood cells. It may be an option for people whose doctors plan to use this specific antibiotic to treat their fever.
This trial tests whether it is safe to stop antibiotics earlier than usual in patients with a low white blood cell count (neutropenia) who have had a fever but have been fever-free for 48 hours. The goal is to reduce unnecessary antibiotic use and its side effects.
This study looks at whether a common side effect (bone pain) from a medicine that boosts white blood cells (called G-CSF) is related to the number of neutrophils (a type of white blood cell) in your blood. If you join, you will receive the medicine as part of your normal chemotherapy routine, and the researchers will track your blood counts and any bone pain you experience.
This trial tests a medication that aims to reduce the risk of dangerously low white blood cell counts (neutropenia) after chemotherapy combined with immunotherapy for certain advanced lung or esophageal cancers. It may help prevent infections and other complications, making treatment safer.
This trial tests whether a small home monitoring device can help keep children safer after chemotherapy, especially when they're at risk of a low white blood cell count (neutropenia). If your child is starting treatment, this device might help you catch early signs of infection and avoid complications.
Hear when a new Febrile Neutropenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.